Vitamin/Mineral Supplement for Children and Adults With Autism
Launched by ARIZONA STATE UNIVERSITY · Oct 19, 2010
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
The major goal of this study is to determine the effect of this vitamin/mineral supplement on levels of vitamins, minerals, neurotransmitters, and biomarkers for nutritional deficiencies. The study design is a randomized, double-blind, placebo-controlled. Blood and urine measurements will be measured at the beginning of the study in children with autism and typical children. Then, the children with autism will be given the supplement or placebo for 12 weeks, and then their blood and urine will be re-measured.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. age 3-60 years old;
- • 2. Autism Group: diagnosis of autism, pervasive developmental disorder/not otherwise specified (PDD/NOS), or Asperger's by a psychiatrist or similar professional
- • 3. Control Group: in good mental and physical health, and no siblings with autism spectrum disorders, and no evidence of Attention Deficit Disorder by parent report
- Exclusion Criteria:
- • 1. Usage of a vitamin/mineral supplement in the last 2 months
- • 2. Current use of any chelation treatment
About Arizona State University
Arizona State University (ASU) is a leading research institution dedicated to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, ASU leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical research aimed at improving patient outcomes and contributing to the scientific community. With a commitment to ethical research practices and collaboration with healthcare professionals, ASU strives to translate research findings into practical applications that benefit society. The university's focus on community engagement and real-world impact underscores its role as a pivotal player in the advancement of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tempe, Arizona, United States
Patients applied
Trial Officials
James B. Adams, PhD
Principal Investigator
Arizona State University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials